Portrait of Moskowitz, Jared

Moskowitz, Jared

U.S. Representative FL-23 Democratic Party

Congressional stock trade history disclosed under the STOCK Act, parsed and scored by FilingIQ.

Disclosed trades
304
Buys / sells
69% / 31%
Last trade
Mar 31, 2026
Last filing
Apr 30, 2026

Latest disclosed trades

Latest 10 of 304
Ticker Type Traded
GD Buy Mar 31, 2026
CMI Sell Mar 31, 2026
PANW Buy Mar 31, 2026
CAT Sell Mar 31, 2026
AVGO Buy Mar 31, 2026
GE Buy Mar 31, 2026
PH Buy Mar 31, 2026
MSI Buy Mar 31, 2026
COR Buy Mar 31, 2026
CB Buy Mar 31, 2026

Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window, and to see the FilingIQ Score on every trade.

Moskowitz, Jared stock trade activity

FilingIQ has indexed 304 congressional stock trade disclosures for Moskowitz, Jared. The most recent disclosed transaction is dated Mar 31, 2026.

Across the full history, 210 purchases and 94 sales have been disclosed under the STOCK Act.

Top tickers traded by Moskowitz, Jared

Frequently asked

How many stock trades has Moskowitz, Jared disclosed?
FilingIQ tracks 304 Periodic Transaction Report disclosures for Moskowitz, Jared, with the most recent dated Mar 31, 2026. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
Is Moskowitz, Jared a net buyer or net seller?
Across the disclosed trade history, 210 (69%) were purchases and 94 (31%) were sales. Compensation and exchanges are filtered out of these counts.
Where does FilingIQ's data on Moskowitz, Jared come from?
Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.

Methodology & sources

Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.